Interleukin-2 (IL-2) or aldesleukin is a recombinant and purified interleukin protein and lymphocyte growth factor.
The drug is indicated for use in the treatment of metastatic melanoma and renal cell carcinoma. Numerous black box warnings are associated with the use of IL-2. It is highly regulated and only available through a Specialty Distribution network.